Articles tagged with “biotech-ai-use-cases”

A 2026 methodology guide to running an AI opportunity assessment in biotech: readiness diagnostics, a five-axis use case prioritization matrix, FDA and EU AI Act context, and five named case studies.

A 2026 framework for prioritizing biotech AI use cases by impact, data readiness, and regulatory risk, with verified adoption, ROI, and FDA governance data.

A 2026 data-driven benchmark of AI enablement in biotech covering adoption surveys, drug discovery market sizing, FDA/EMA guidance, and five real-world case studies including Insilico Medicine and Isomorphic Labs.

A 2026 framework for biotech AI strategy: a five-axis prioritization matrix, FDA/EMA risk tiering, data readiness benchmarks, ROI data, and five named case studies including Insilico, Recursion, and Xaira.